Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
RoslinCT, a UK-based contract development and manufacturing organisation specialised in advanced cell therapies, has secured an undisclosed sum from GHO Capital Partners. The company was spun out of Roslin Institute in 2006 before the institute became a part of University of Edinburgh two years later. It does not appear to have declared any other equity financing. In November 2021, RoslinCT filed a voluntary resolution to wind up the business but it is unclear whether this means GHO’s investment was for…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
